Bone Only Oligometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Body Radiotherapy: A MULTI-Institutional Study

被引:0
|
作者
Onal, C. [1 ,2 ]
Guler, O. C. [3 ]
Hurmuz, P. [4 ]
Yavas, G. [2 ]
Tilki, B. [4 ]
Oymak, E. [5 ]
Yavas, C. [2 ]
Ozyigit, G. [6 ]
机构
[1] Baskent Univ, Adana Turgut Noyan Res & Treatment Ctr, Fac Med, Adana, Turkey
[2] Baskent Univ, Fac Med, Ankara, Turkey
[3] Baskent Univ, Fac Med, Adana Dr Turgut Noyan Res & Treatment Ctr, Dept Radiat Oncol, Adana, Turkey
[4] Hacettepe Univ, Fac Med, Ankara, Turkey
[5] Iskenderun Gelisim Hosp, Div Radiat Oncol, Antakya, Turkey
[6] Hacettepe Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2466
引用
收藏
页码:E209 / E209
页数:1
相关论文
共 50 条
  • [1] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Onal, Cem
    Guler, Ozan Cem
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Oymak, Ezgi
    Yavas, Cagdas
    Ozyigit, Gokhan
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 940 - 948
  • [2] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Cem Onal
    Ozan Cem Guler
    Pervin Hurmuz
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    [J]. Strahlentherapie und Onkologie, 2022, 198 : 940 - 948
  • [3] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Onal, Cem
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Yavas, Guler
    Hurmuz, Pervin
    Yavas, Cagdas
    Ozyigit, Gokhan
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (05) : 456 - 464
  • [4] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Guler Yavas
    Pervin Hurmuz
    Cagdas Yavas
    Gokhan Ozyigit
    [J]. Strahlentherapie und Onkologie, 2023, 199 : 456 - 464
  • [5] Outcomes and Toxicities in Oligometastatic Patients Treated With Stereotactic Body Radiotherapy for Adrenal Gland Metastases: A Multi-Institutional Study
    Baydoun, A.
    Chen, H.
    Poon, I.
    Badellino, S.
    Dagan, R.
    Erler, D.
    Foote, M. C.
    Louie, A. V.
    Redmond, K. J.
    Ricardi, U.
    Sahgal, A.
    Biswas, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E474 - E474
  • [6] Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
    Baydoun, A.
    Chen, H.
    Poon, I
    Badellino, S.
    Dagan, R.
    Erler, D.
    Foote, M. C.
    Louie, A., V
    Redmond, K. J.
    Ricardi, U.
    Sahgal, A.
    Biswas, T.
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 33 : 159 - 164
  • [7] SBRT in patients with oligometastatic renal cell carcinoma: A multi-institutional analysis
    Guler, O. C.
    Hurmuz, P.
    Ozyigit, G.
    Onal, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1208 - S1209
  • [8] Stereotactic radiotherapy for oligometastatic patients with renal cell carcinoma
    Cecconi, A.
    Piperno, G.
    Ferrari, A.
    Rondi, E.
    Vigorito, S.
    Zerini, D.
    Cattani, F.
    Nole, F.
    De Cobelli, O.
    Jereczek-Fossa, B. A.
    Orecchia, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S648 - S648
  • [9] STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH OLIGOMETASTATIC RENAL CELL CARCINOMA
    Cecconi, Agnese
    Jereczek-Fossa, Barbara Alicja
    Ferrari, Annamaria
    Rocca, Maria Cossu
    Rondi, Elena
    Piperno, Gaia
    Vigorito, Sabrina
    Cattani, Federica
    Zerini, Dario
    Cioffi, Antonio
    Ferro, Matteo
    Nole, Franco
    Verri, Elena
    De Cobelli, Ottavio
    Orecchia, Roberto
    [J]. ANTICANCER RESEARCH, 2017, 37 (04) : 2109 - 2110
  • [10] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595